Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
Authors:
- George T GrossbergGGGeorge T Grossberg
- 25 May 2010
- journal article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 11 (10) , 1765-1771
Abstract
(2010). Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease. Expert Opinion on Pharmacotherapy: Vol. 11, No. 10, pp. 1765-1771. doi: 10.1517/14656566.2010.493874Keywords
This publication has 31 references indexed in Scilit:
- Update on the use of memantine in Alzheimer’s diseaseNeuropsychiatric Disease and Treatment, 2009
- Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs DiseaseCNS Drugs, 2009
- Memantine for the Treatment of Alzheimer???s DiseaseDrug Safety, 2008
- Safety and tolerability of once‐daily versus twice‐daily memantine: a randomised, double‐blind study in moderate to severe Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2007
- Memantine PharmacotherapyClinical Pharmacokinetics, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- GalantamineDrugs, 2000
- Competence of Long-Term Care Residents to Participate in Decisions About Their Medical Care: A Brief, Objective AssessmentThe Gerontologist, 1995
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978